Kevin Kadede1, Theodore Ruel, Jane Kabami, Emmanuel Ssemmondo, Norton Sang, Dalsone Kwarisiima, Elizabeth Bukusi, Craig R Cohen, Teri Liegler, Tamara D Clark, Edwin D Charlebois, Maya L Petersen, Moses R Kamya, Diane V Havlir, Gabriel Chamie. 1. aCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya bDivision of Infectious Disease and Global Health, Department of Pediatrics, University of California San Francisco, San Francisco, California, USA cMakerere University-University of California Research Collaboration, Kampala, Uganda dDepartment of Obstetrics, Gynecology and Reproductive Sciences eDivision of HIV, Infectious Diseases and Global Medicine fCenter for AIDS Prevention Studies, University of California San Francisco (UCSF), San Francisco gUniversity of California Berkeley School of Public Health, Berkeley, California, USA hDepartment of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Abstract
OBJECTIVE: We sought to increase adolescent HIV testing across rural communities in east Africa and identify predictors of undiagnosed HIV. DESIGN: Hybrid mobile testing. METHODS: We enumerated 116 326 adolescents (10-24 years) in 32 communities of Uganda and Kenya ( SEARCH: NCT01864603): 98 694 (85%) reported stable (≥6 months of prior year) residence. In each community we performed hybrid testing: 2-week multidisease community health campaign that included HIV testing, followed by home-based testing of community health campaign nonparticipants. We measured adolescent HIV testing coverage and prevalence, and determined predictors of newly diagnosed HIV among HIV-infected adolescents using multivariable logistic regression. RESULTS: A total of 86 421 (88%) stable adolescents tested for HIV; coverage was 86, 90, and 88% in early (10-14), mid (15-17), and late (18-24) adolescents, respectively. Self-reported prior testing was 9, 26, and 55% in early, mid, and late adolescents tested, respectively. HIV prevalence among adolescents tested was 1.6 and 0.6% in Ugandan women and men, and 7.1 and 1.5% in Kenyan women and men, respectively. Prevalence increased in mid-adolescence for women and late adolescence for men. Among HIV-infected adolescents, 58% reported newly diagnosed HIV. In multivariate analysis of HIV-infected adolescents, predictors of newly diagnosed HIV included male sex [odds ratio (OR) = 1.97 (95% confidence interval (CI): 1.42-2.73)], Ugandan residence [OR = 2.63 (95% CI: 2.08-3.31)], and single status [OR = 1.62 (95% CI: 1.23-2.14) vs. married)]. CONCLUSIONS: The SEARCH hybrid strategy tested 88% of stable adolescents for HIV, a substantial increase over the 28% reporting prior testing. The majority (57%) of HIV-infected adolescents were new diagnoses. Mobile HIV testing for adults should be leveraged to reach adolescents for HIV treatment and prevention.
OBJECTIVE: We sought to increase adolescent HIV testing across rural communities in east Africa and identify predictors of undiagnosed HIV. DESIGN: Hybrid mobile testing. METHODS: We enumerated 116 326 adolescents (10-24 years) in 32 communities of Uganda and Kenya ( SEARCH: NCT01864603): 98 694 (85%) reported stable (≥6 months of prior year) residence. In each community we performed hybrid testing: 2-week multidisease community health campaign that included HIV testing, followed by home-based testing of community health campaign nonparticipants. We measured adolescent HIV testing coverage and prevalence, and determined predictors of newly diagnosed HIV among HIV-infected adolescents using multivariable logistic regression. RESULTS: A total of 86 421 (88%) stable adolescents tested for HIV; coverage was 86, 90, and 88% in early (10-14), mid (15-17), and late (18-24) adolescents, respectively. Self-reported prior testing was 9, 26, and 55% in early, mid, and late adolescents tested, respectively. HIV prevalence among adolescents tested was 1.6 and 0.6% in Ugandan women and men, and 7.1 and 1.5% in Kenyan women and men, respectively. Prevalence increased in mid-adolescence for women and late adolescence for men. Among HIV-infected adolescents, 58% reported newly diagnosed HIV. In multivariate analysis of HIV-infected adolescents, predictors of newly diagnosed HIV included male sex [odds ratio (OR) = 1.97 (95% confidence interval (CI): 1.42-2.73)], Ugandan residence [OR = 2.63 (95% CI: 2.08-3.31)], and single status [OR = 1.62 (95% CI: 1.23-2.14) vs. married)]. CONCLUSIONS: The SEARCH hybrid strategy tested 88% of stable adolescents for HIV, a substantial increase over the 28% reporting prior testing. The majority (57%) of HIV-infected adolescents were new diagnoses. Mobile HIV testing for adults should be leveraged to reach adolescents for HIV treatment and prevention.
Authors: Audrey E Pettifor; Helen V Rees; Immo Kleinschmidt; Annie E Steffenson; Catherine MacPhail; Lindiwe Hlongwa-Madikizela; Kerry Vermaak; Nancy S Padian Journal: AIDS Date: 2005-09-23 Impact factor: 4.177
Authors: Nora E Rosenberg; Daniel Westreich; Till Bärnighausen; William C Miller; Frieda Behets; Suzanne Maman; Marie-Louise Newell; Audrey Pettifor Journal: AIDS Date: 2013-11-13 Impact factor: 4.177
Authors: Robert J Kelly; Ronald H Gray; Nelson K Sewankambo; David Serwadda; Fred Wabwire-Mangen; Tom Lutalo; Maria J Wawer Journal: J Acquir Immune Defic Syndr Date: 2003-04-01 Impact factor: 3.731
Authors: Simon Gregson; Constance A Nyamukapa; Geoffrey P Garnett; Peter R Mason; Tom Zhuwau; Michel Caraël; Stephen K Chandiwana; Roy M Anderson Journal: Lancet Date: 2002-06-01 Impact factor: 79.321
Authors: Ann E Kurth; Michelle A Lally; Augustine T Choko; Irene W Inwani; J Dennis Fortenberry Journal: J Int AIDS Soc Date: 2015-02-26 Impact factor: 5.396
Authors: Gabriel Chamie; Tamara D Clark; Jane Kabami; Kevin Kadede; Emmanuel Ssemmondo; Rachel Steinfeld; Geoff Lavoy; Dalsone Kwarisiima; Norton Sang; Vivek Jain; Harsha Thirumurthy; Teri Liegler; Laura B Balzer; Maya L Petersen; Craig R Cohen; Elizabeth A Bukusi; Moses R Kamya; Diane V Havlir; Edwin D Charlebois Journal: Lancet HIV Date: 2016-01-26 Impact factor: 12.767
Authors: Patricia Ong'wen; Benard O Samba; Michelle Moghadassi; Nicollate Okoko; Elizabeth A Bukusi; Craig R Cohen; Hilary T Wolf Journal: AIDS Behav Date: 2020-02
Authors: James Ayieko; Gabriel Chamie; Laura Balzer; Dalsone Kwarisiima; Jane Kabami; Norton Sang; Craig R Cohen; Elizabeth A Bukusi; Tamara D Clark; Albert Plenty; Edwin D Charlebois; Maya Petersen; Moses Kamya; Diane V Havlir; Theodore Ruel Journal: Pediatr Infect Dis J Date: 2018-12 Impact factor: 2.129
Authors: Catherine A Koss; James Ayieko; Florence Mwangwa; Asiphas Owaraganise; Dalsone Kwarisiima; Laura B Balzer; Albert Plenty; Norton Sang; Jane Kabami; Theodore D Ruel; Douglas Black; Carol S Camlin; Craig R Cohen; Elizabeth A Bukusi; Tamara D Clark; Edwin D Charlebois; Maya L Petersen; Moses R Kamya; Diane V Havlir Journal: Clin Infect Dis Date: 2018-11-28 Impact factor: 9.079
Authors: Matthew D Hickey; Thomas A Odeny; Maya Petersen; Torsten B Neilands; Nancy Padian; Nathan Ford; Zachary Matthay; David Hoos; Meg Doherty; Chris Beryer; Stefan Baral; Elvin H Geng Journal: Implement Sci Date: 2017-08-08 Impact factor: 7.327
Authors: Jasmine Buttolph; Irene Inwani; Kawango Agot; Charles M Cleland; Peter Cherutich; James N Kiarie; Alfred Osoti; Connie L Celum; Jared M Baeten; Ruth Nduati; John Kinuthia; Timothy B Hallett; Ramzi Alsallaq; Ann E Kurth Journal: JMIR Res Protoc Date: 2017-03-08
Authors: Ramzi A Alsallaq; Jasmine Buttolph; Charles M Cleland; Timothy Hallett; Irene Inwani; Kawango Agot; Ann E Kurth Journal: PLoS One Date: 2017-04-12 Impact factor: 3.240